Survey Makes Positive Comments Regarding Medtronic's (MDT) Meniett Therapy
More News related to MDT
- Dividend Increases At Record Low, Dividend Cuts Highest In Over 50 Years
- Medtronic (MDT) Granted 510(k) Clearance by FDA for LUCAS(TM) 2
- FDA Grants LUCAS(TM) 2 Chest Compression System 510(k) Clearance in the United States
- David Moenning’s Daily State of the Markets: 6/26
- Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
More News related to Corporate News
- Argon ST (STST) Awarded $8.3 Million to Provide U.S. Army Technology Enabler Development
- McKesson (MCK) Renews Pharmaceutical Distribution Agreement with CVS Caremark (CVS)
- Oclaro (OCLR) Closes Deal with Newport (NEWP) to Exchange Strategic Assets
- Cardinal Health (CAH) Renews Distribution Agreement with CVS Caremark (CVS) Through Mid-2013
- Caraco Pharmaceutical Laboratories (CPD) Announces Its Reducing Its Workforce By 350 Employees
Results of a survey published in the August 2007 issue of Otology & Neurotology indicates that the Meniett Low Pressure Pulse Generator manufactured by Medtronic, Inc. (NYSE: MDT) is the preferred treatment method after diet modification for patients diagnosed with Meniere's Disease in an only hearing ear. The survey was conducted among a nonrandom sample of clinically active members of the American Otological Society and the American Neurotology Society by researchers from the Division of Otolaryngology - Head and Neck Surgery at Penn State Milton S. Hershey Medical Center.
When asked what they would offer if initial treatment failed, respondents chose the Meniett® device first and most frequently over therapies such as intratympanic corticosteroids, endolymphatic sac mastoid shunt, intratympanic gentamicin perfusion and endolymphatic sac vein decompression.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
